Gland Pharma

Shenzhen Hepalink Pharmaceutical Group Co., Ltd., founded in 1998 and headquartered in Shenzhen, People's Republic of China, operates as an international pharmaceutical company. It is involved in the development, production, and distribution of a wide array of pharmaceutical goods, serving markets in Hong Kong, the United States, Europe, Mainland China, and other global regions. The company's operations are structured across four primary divisions. One key area is Finished Dose Pharmaceutical Products, prominently featuring enoxaparin sodium injection. Another significant segment focuses on Active Pharmaceutical Ingredients (API), supplying essential components like heparin sodium API, enoxaparin sodium API, and other specialized products such as pancreatin API. Hepalink also provides comprehensive services through its Contract Development and Manufacturing Organization (CDMO) arm, which encompasses research and development, manufacturing, quality assurance, and program management. Within its CDMO capabilities, the company is actively involved in creating advanced biopharmaceutical products, including recombinant pharmaceuticals, critical non-viral vectors, gene therapy intermediates, and naturally derived pharmaceutical substances. Beyond its core pharmaceutical activities, Hepalink diversifies its business interests through property management, investment management and advisory services, biopharmaceutical technology development and consulting, and equity and venture capital investments. The company also conducts research, development, and production of biopharmaceuticals, trades medical and biopharmaceutical products, and offers various pharmaceutical-related services. The company officially changed its name from Shenzhen Hepalink Pharmaceutical Co., Ltd. to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017.

Sai Parenterals Limited is a diversified multinational pharmaceutical manufacturer founded in 2001, headquartered in Hyderabad, Telangana, with operations originating in Andhra Pradesh. The company specializes in branded generic formulations, injectables, and contract development services.

Neuland Laboratories LimitedPharmaceuticalsIndia

67% matchPublic

Neuland Laboratories Limited is a trusted pharmaceutical and active pharmaceutical ingredient (API) manufacturing company headquartered in Hyderabad, Telangana, India.

Kilitch Drugs (India) LimitedKILITCH · PharmaceuticalsIndia

66% matchPublic

Kilitch Drugs (India) Limited is a global pharmaceutical company and contract manufacturer that produces a wide range of pharmaceutical formulations, including parenteral products, liquid injectables, antibiotics, nutraceuticals, and over-the-counter medications. The company serves healthcare professionals and patients internationally by supplying certified pharmaceutical products across various dosage forms.

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical ingredients (APIs) and chemical intermediates, which serve as crucial building blocks for final drug products. Additionally, PSAI provides contract research services and produces custom-specified APIs and steroids for clients. The Proprietary Products segment is dedicated to the research and advancement of unique pharmaceutical formulations. The Others segment is actively involved in developing treatments, primarily for oncology (cancer) and inflammatory conditions. Dr. Reddy's addresses a broad spectrum of therapeutic areas, including gastrointestinal issues, cardiovascular health, diabetes, dermatological concerns, cancer, respiratory diseases, oral health, urological disorders, and nephrological conditions. The company has also established a partnership with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists designed for immuno-oncology and precision oncology targets. Founded in 1984, Dr. Reddy's Laboratories Limited maintains its principal office in Hyderabad, India.

Nectar Lifesciences Limited is a pharmaceutical manufacturer based in India that produces Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and finished dosage forms, specializing in cephalosporin antibiotics. The company also offers contract manufacturing services for solid dosage forms and produces empty hard gelatin capsules for global pharmaceutical markets.